Articles tagged with Antibiotics
A comprehensive study published in Archives of Internal Medicine reveals that nearly 70% of Americans with dementia receive antibiotic medications, particularly in the final stages of their disease. The researchers warn that this practice poses a significant public health risk due to the emergence of antimicrobial resistance.
A study of 214 residents found that nearly two-thirds received antibiotics during their stay, with most prescriptions given in the final weeks of life. The excessive use of antibiotics raises concerns about individual treatment burden and the development of antimicrobial resistance in nursing homes.
Researchers at Ohio State University identified two proteins, MprF1 and MprF2, that contribute to bacterial resistance by altering the electrical charge of cell membranes. This finding could lead to the development of new drugs targeting bacterial resistance at its cellular source.
Researchers suggest that minocycline can limit Japanese Encephalitis (JE) death by reducing neuronal death, microgliosis, and viral titre. The study found that treatment with minocycline provides complete protection against experimental JE, improving behavioral outcome as well.
A study in Ethiopia found that biannual mass azithromycin treatment significantly reduced eye infections caused by chlamydia in preschool children, from 42.6% to 0.9%, compared to annual treatment, which reduced infections by 6-fold.
A new technique developed by a University of Central Florida chemist will help physicians more quickly identify the bacterial infections patients have so they can be treated in hours instead of days. The method uses gold nanoparticles coated with a sugar and a protein that binds to sugars, allowing for rapid testing of antibiotics.
A meta-analysis of previous studies found that antibiotics do not significantly reduce fluid buildup in children with middle ear infections. The condition can lead to hearing loss and language development delays. Researchers recommend against prescribing antibiotics to prevent middle ear effusion.
A new mathematical model has identified minimizing antibiotic treatment duration as the optimal strategy for controlling hospital-borne antibiotic-resistant bacteria epidemics. By starting treatments early and administering drugs for shorter periods, the risk of cross-infection by resistant bacteria can be significantly reduced.
Researchers have discovered a weakness in the defenses of the anthrax bacterium that could be exploited to produce new antibiotics. Nitric oxide is a critical part of Bacillus anthracis's defense against the immune response, and disrupting this system could make it vulnerable to attack by macrophages.
A recent study found that Arctic birds carry antibiotics-resistant bacteria, highlighting the global spread of antibiotic resistance. The researchers believe immigrating birds from Southeast Asia may have introduced these resistant bacteria to the tundra.
A study found that home-based treatment of severe pneumonia in children with oral antibiotics is equivalent to in-hospital treatment, suggesting a revision of WHO guidelines. This finding has significant public health implications for improving access to care and reducing mortality from pneumonia.
Researchers have found that rifapentine, an older antibiotic, is a potent treatment for tuberculosis when used at high doses. Clinical trials are underway to test its effectiveness in reducing treatment time from six months to three months or less.
A study suggests that combining a medication for multiple sclerosis with an antibiotic may slow the disease's progression. The treatment combination showed promising results in reducing lesions and disability scores.
Researchers at the University of Manchester have pioneered new methods to modify antibiotics' molecular structure, enabling the development of new types of antibiotics capable of combating increasingly resistant bacteria. This innovation provides access to thousands of lipopeptide variants that cannot be produced easily in any other way.
A study found that common treatments for acute sinusitis, including antibiotics and topical steroids, were not more effective than placebo in altering symptom severity, duration, or natural history. Topical steroids were likely to be effective in patients with less severe symptoms at presentation.
Scientists have developed a DNA-based therapy that can switch off antibiotic resistance in bacteria by delivering a short stretch of DNA as a decoy. This technology has the potential to slash the development time of new drugs and could give fresh patent life to existing antibiotics.
Researchers found that joint inflammation persists in patients with antibiotic-refractory Lyme arthritis, despite the spirochetes being killed. Antibody titers declined to similar levels after 4-6 months of antibiotic therapy, regardless of treatment response.
Researchers found that high-intensity manure management practices can increase the rate of antibiotic dissipation, but were not effective at reducing antibiotic resistance genes. Longer treatment times may be necessary to achieve significant reductions in both antibiotics and ARG.
Scientists found that 61% of hospital samples tested positive for ESBL-producing bacteria, which can break down common antibiotics. The spread of these strains has significant economic and health consequences, including longer treatment times and increased costs.
The American Thoracic Society has released new clinical standards for treating cystic fibrosis, focusing on aerosolized antibiotics and DNase for patients with moderate to severe lung disease. The guidelines aim to improve lung function, reduce exacerbations, and increase life expectancy.
A strain of bacteria resistant to all approved pediatric antibiotics has been discovered, according to researchers at the University of Rochester Medical Center. The 19A strain was found in children with persistent ear infections despite antibiotic treatment, highlighting concerns over potential long-term consequences.
A new strain of Streptococcus pneumoniae bacteria has been detected that is resistant to all FDA-approved antibiotics and not covered by the pneumococcal 7-valent conjugate vaccine. This strain was found in nine cases, resulting in unsuccessful treatment with multiple antibiotics.
Researchers have discovered a molecular mechanism that could lead to the development of new, potent antibiotics. The compounds mimic natural peptides and create 'holes' in bacterial membranes, causing cell death.
A study found that Dutch GPs unnecessarily prescribe antibiotics for respiratory tract infections based on arbitrary diagnostic labelling and patient symptoms. The over-prescription of antibiotics poses significant risks due to resistance and costs.
The study proposes new methods to detect pesticide residue (carbamates) and antibiotic residue (sulfonamides) in water, plant foods and animal-derived foods. The developed methods are innovative, sensitive, and environmentally friendly alternatives to existing detection techniques.
A new antibiotic combination could dramatically shorten TB treatment time from six months to four months, with a cure rate increasing by 17 percent after two months of therapy. Researchers say the shorter treatment period may also reduce transmission and improve drug compliance.
Researchers will develop a faster, more sensitive biosensor to detect bacterial infections in human clinical fluid samples. The goal is to enable point-of-care diagnostics and aid antibiotic treatment selection within two hours.
Researchers at UW-Madison developed a novel enzyme that can decorate chemical molecules with natural sugars, altering their biological effects. The new enzyme has the potential to create a range of therapeutic agents for cancer treatment and infection prevention.
Temple University's Department of Emergency Medicine is participating in a nationwide study to identify the best outpatient therapy for community-acquired MRSA, a growing concern with antibiotic-resistant properties. The research aims to determine effective treatments and gain FDA approval for generic antibiotics.
Dr. Richard Guerrant receives funding to develop a new treatment approach for C. difficile by targeting its toxins instead of the bacteria itself, aiming to prevent deadly complications and reduce antibiotic use.
Researchers at the University of Illinois Chicago have identified new sites on bacterial protein-making machinery where antibiotics can be delivered to treat infections. The study found that targeting specific regions of the ribosome, a crucial cellular component, may provide a novel approach to developing effective antibiotics.
New clues from immune system molecules hold hope for overcoming antibiotic resistance, with shared structural and functional characteristics enabling these molecules to inhibit or kill microbial pathogens.
Researchers have created synthetic antibiotics called Teflon AMPs that are more resistant to bacterial defenses than their natural counterparts. These compounds mimic the immune system's early line of defense and show promise in battling a range of infections, including those caused by antibiotic-resistant bacteria.
Researchers used computer analysis to identify potential new antibiotics, such as lovastatin and gentisic acid, which show promise against emerging bacterial threats. The approach could save time and lives during outbreaks or bioterrorism attacks.
Two new five-year contracts will study oral, off-patent antibiotics for treating skin and soft tissue CA-MRSA infections. If successful, these antibiotics could be used to delay resistance development to vancomycin.
The study aims to identify effective off-patent antibiotics for treating uncomplicated skin and soft tissue infections caused by MRSA. Researchers hope to find an optimal treatment to stop progression of serious infections or prevent recurrence, with Olive View–UCLA Medical Center as the principal study site.
A new University of Missouri-Columbia study is investigating whether family pets could be a reservoir for infections of multi-resistant bacteria in humans. Researchers are collecting samples from 750 pairs of owners and pets to track the spread of diseases such as MRSA.
Research by Dr James Chin and colleagues reveals that antibiotics not only kill bad bacteria but also maintain a pool of resistant genes within microbial communities. This means that subsequent therapy with another antibiotic may be ineffective due to increased resistance.
Researchers used powerful imaging techniques to study the atomic level interactions between bacteria and antibiotics, revealing a key enzyme structure that enables gene expression. The findings provide insights into potential new antibiotic designs that can prevent bacterial resistance.
General Practitioners (GPs) are still over-prescribing antibiotics for common infections like sore throats and sinusitis, hindering efforts to combat antibiotic resistance. The analysis of the world's largest primary care database found that prescriptions for these conditions rose to 80% despite guidance warnings.
A review of type 2 diabetes treatment found older agents have similar or superior effects on glycemic control and intermediate endpoints compared to newer, pricier medications. Gonorrhea is becoming resistant to fluoroquinolone antibiotics, leading to recommendations for alternative treatments.
Food crops like corn, lettuce, and potato take up antibiotics from soils treated with manure containing the antibiotic Sulfamethazine. This raises concerns about the potential for contamination of the human food supply, particularly among vulnerable populations like young children who may experience allergic reactions.
A study published in JAMA Network found that antibiotic treatment after a first urinary tract infection (UTI) in children may not reduce the risk of recurrent UTIs, but increases the risk of resistant infections. The study identified risk factors for recurrent UTI and estimated the effectiveness of antimicrobials in preventing recurrence.
Researchers have successfully sequenced the genome of Salinispora tropica, a bacterium discovered in Bahamian mud with potential to produce compounds showing promise in treating diseases such as cancer. The decoded genome reveals an impressive 10% of genes dedicated to producing molecules for antibiotics and anticancer agents.
The American Academy of Neurology has published a new guideline for treating Lyme disease affecting the nervous system, finding conventional antibiotic courses highly effective. Prolonged antibiotic treatment does not improve outcomes for patients with persistent symptoms after standard therapy.
Scientists at Universitat Autonoma de Barcelona developed a new electro-chemical biosensor that detects pesticides and antibiotics in food with high sensitivity and portability. The sensor can detect levels of atrazine and sulphanilamides below maximum allowed concentrations, making it easier to control food safety.
Researchers at the University of Illinois Chicago have discovered how antibiotic linezolid inhibits bacterial growth. By binding to ribosomes, linezolid kills bacteria and disrupts protein synthesis. The study provides new insights into the mechanism of action and potential improvements for the drug.
A randomized, double-blind controlled trial is being conducted to evaluate the effectiveness of topical honey in healing diabetic ulcers. The study aims to provide a cost-effective alternative to antibiotics, which are often ineffective against drug-resistant bacteria.
A UC Irvine study found that certain antibiotics reduce bacteria in ticks, leading to retarded growth and reduced reproduction. The discovery could lead to safer and more effective ways to control ticks and the diseases they transmit.
Thomas Steitz received the 2007 Gairdner International Award for his work on the structure and function of the large subunit of the ribosome, which has led to a better understanding of human disease and the development of new antibiotics. His research has also highlighted the importance of basic discoveries in medical science.
Researchers at University of Wisconsin-Madison have devised a method to tackle antibiotic resistance, identifying four promising new compounds with preliminary antibacterial activity. The compounds show promise against MRSA and other Gram-positive bacteria, but further research is needed to understand their mechanism of action.
A research team from the University of Illinois and the University of Wisconsin aims to discover, engineer and produce promising phosphonate-based antibiotics. The project seeks alternatives to standard antibiotics due to growing concerns about antimicrobial resistance.
Researchers have discovered a weakness in the armour that protects B. cenocepacia from antibiotics, identifying a key sugar required for its protection. This finding may lead to novel molecules to disrupt its synthesis and develop new treatments.
Most dental patients with heart disease no longer need antibiotics before dental procedures to prevent infective endocarditis. New guidelines recommend antibiotics only for patients at greatest risk, including those with artificial heart valves or congenital heart conditions.
A new study suggests that antibiotic therapy for diabetic foot infections can be predicted using specific laboratory and clinical tests. The study found that deep wounds or high white blood cell counts significantly increased the risk of bad outcomes.
Researchers discovered that prolonged exposure to antibiotics triggers a genetic response in E. coli, resulting in increased efflux pump activity and altered outer membrane porin protein levels. This study highlights the critical role of genetic adaptation in antibiotic resistance.
Researchers at Duke University Medical Center found that forskolin flushes out hiding colonies of bacteria in the bladder, making them susceptible to antibiotic treatment. The study shows great promise for a new approach to treating recurring urinary tract infections.
Researchers have found the same plasmids responsible for antibiotic resistance in common bacteria also present in the plague bacillus Yersinia pestis, raising concerns about its potential spread. This discovery highlights a significant public health risk as MDR Y. pestis could rapidly evolve and affect human health.
TB patients must take long-term therapy due to a correlation between bacterial burden and time to cure. Researchers suggest that non-replicating bacteria are not TB-specific and that understanding this phenomenon can lead to shorter treatment durations for recalcitrant bacterial infections.
A recent study found that antibiotics are prescribed for approximately 82% of acute and chronic sinus infections, despite viruses being the most frequent cause. This overprescription has significant concerns, including drug resistance and virulent bacteria, as well as increased healthcare costs.